Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Figs. 2C and 4C were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Yang S, Zhang Y, Zhao X, Wang J and Shang J: microRNA‐361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non‐small‐cell lung cancer cells. Mol Med Rep 14: 5415‐5421, 2016]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 16: 3557‐3564, 2017; DOI: 10.3892/mmr.2017.7000]

Retraction Note to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway

Retraction Note: P300 Promotes Proliferation, Migration, and Invasion Via Inducing Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer Cells

Retraction Note: Microrna-140-5p Inhibits Colorectal Cancer Invasion and Metastasis by Targeting ADAMTS5 and IGFBP5

Retraction Note: MicroRNA-30d Promotes Angiogenesis and Tumor Growth Via MYPT1/c-JUN/VEGFA Pathway and Predicts Aggressive Outcome in Prostate Cancer

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

Retraction Note: Microrna-15B-5p Encapsulated by M2 Macrophage-Derived Extracellular Vesicles Promotes Gastric Cancer Metastasis by Targeting BRMS1 and Suppressing DAPK1 Transcription

Retraction Note: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2

RETRACTION: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2 (Retraction of Vol 7, art no 4637, 2017)

Retraction Note: Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548

Retraction Note: MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by downregulating LHX2

RETRACTION: p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells (Retraction of Vol 18, art no 641, 2018)

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

Retraction Note: Decreased Expression of Mir-939 Contributes to Chemoresistance and Metastasis of Gastric Cancer Via Dysregulation of SLC34A2 and Raf/MEK/ERK Pathway

Retraction Notice To: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells

Retraction Note: MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1

[Retracted] miRNA‐490‐3p promotes the metastatic progression of invasive ductal carcinoma

Retraction Note: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer

[Retracted] Upregulation of microRNA‐181b inhibits CCL18‐induced breast cancer cell metastasis and invasion via the NF‐κB signaling pathway

Retraction Note: A positive feedback loop consisting of C12orf59/NF-κB/CDH11 promotes gastric cancer invasion and metastasis

Retraction Note: TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells’ invasion

Retraction Notice to: MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer